BREAKING NEWS Moderna to apply for Emergency Use Authorization for vaccine Full Story

Statins' benefits beyond heart health aren't clear-cut, analysis says

Despite some studies suggesting that statin drugs have ...

Posted: Oct 9, 2018 9:27 AM
Updated: Oct 9, 2018 9:27 AM

Despite some studies suggesting that statin drugs have benefits beyond cardiovascular health, for such issues as cancer and Alzheimer's, a broad new analysis says there's a lack of compelling evidence linking such benefits to statins -- and, thus, little reason to change recommendations for who gets these cholesterol-lowering meds and why.

The drugs are commonly prescribed to prevent heart disease in individuals above a certain risk level, but the new analysis -- published Monday in the journal Annals of Internal Medicine -- looked at 278 other health conditions and effects.

Cardiovascular disease

Diseases and disorders

Health and medical

Heart disease

Breast cancer

Business and industry sectors

Business, economy and trade

Cancer

Chronic diseases

Drug safety

Drug safety, efficacy and availability

Kidney disease

Pharmaceutical industry

Pharmaceuticals and biotechnology

Pharmaceuticals and prescription drugs

Urogenital disorders and injuries

Agriculture, forestry, and commercial fishing

Forestry

Timber industry

"I was surprised by the amount of outcomes we identified to have been linked with statins," study author Evropi Theodoratou, a researcher at the University of Edinburgh, wrote in an email. "However, we only identified a dearth of convincing evidence that statins had a major role" in these outcomes.

The analysis found limited evidence of positive outcomes related to cancer, dementia, kidney disease and chronic obstructive pulmonary disease, known as COPD. But only one of these outcomes was significant in a randomized trial -- lower all-cause mortality in patients with chronic kidney disease -- and the authors say it could still be driven by the drugs' impact on cardiovascular disease; the two often go hand in hand.

"Clinical guidelines already recognize the benefits of statins in preventing cardiovascular events in patients with chronic kidney disease who are not receiving dialysis. On the other hand, clinical guidelines currently do not indicate the use of statins to improve cancer prognosis or COPD," Theodoratou said. "I am not aware of any serious efforts by doctors to redefine these guidelines."

More testing needed

More than a quarter of Americans over 40 take a statin, the most common type of cholesterol-lowering medication, according to a 2014 report from the US Centers for Disease Control and Prevention. Different statins are sold under brand names such as Lipitor and Crestor.

Michael Pencina, vice dean for data science and information technology at the Duke University School of Medicine, said the analysis was important because people will invariably be on statins for long periods of time for their heart health, but the question remains: What else could those statins be doing, good or bad?

"I think what we are generally missing in the whole statin discussion is the fully integrated risk-benefit analysis," said Pencina, who was not involved in the new study.

Researchers say this doesn't mean these outcomes aren't necessarily null; they just haven't been sufficiently tested yet.

"From the breast cancer perspective, there's a great deal of very consistent evidence both from laboratory models and from epidemiologic studies that demonstrates a lower risk of breast cancer recurrence" for people on a certain type of statins, said Thomas Ahern, an assistant professor of surgery at the Larner College of Medicine at the University of Vermont. Ahern has studied the link between statins and breast cancer but was not involved in the new analysis.

Ahern noted that the new paper omits studies conducted in a lab, which could contain important information. (The study says there is "suggestive" evidence gleaned from observational analyses that recurrence-free breast cancer survival is linked to statins.)

"When it comes down to it, I don't think that their conclusions differ fundamentally from our view, which is that it's high time that statins be definitively tested in breast cancer survivors in an appropriately designed clinical trial," Ahern said.

Pros and cons

Some patients on statins report a number of side effects, such as muscle pain, increased blood sugar and memory problems. But the majority of patients have no side effects at all.

"There was a modest increase in diabetes among people treated with statins, but this evidence is not enough to justify not taking the drugs, which is in accordance to expert consensus," Theodoratou said.

The new analysis detected "no significant effects" of the drugs on a range of side effects, including muscle pain. Theodoratou described this as "reassuring" but cautioned that "we cannot exclude the possibility that some of these harms such as muscle pain may be too rare to rule out with certainty.

"We did not find strong evidence for an association but not all of the original studies had adequately reported side effects. So, we cannot conclude that the drugs do not cause muscle pain," she said.

Doctors have said certain people are "miserable" taking statins, and muscle pain in particular is a commonly reported side effect. The disconnect between these experiences and the new analysis could be explained by how individual studies select patients or how difficult it might be to tell whether muscle symptoms are actually a result of statins, according to the authors.

Experts have described how, the more patients are aware -- and perhaps fearful -- of statins and their side effects, the more likely they are to report those side effects. This phenomenon is known as the nocebo effect, the opposite of the placebo effect.

The new paper reviews previous metaanalyses -- Pencina called it a "summary of summaries" -- but does not closely evaluate individual studies, which may have their own selection bias, inedequate follow-up, missing data, and potential financial conflicts and industry influence.

While studies funded by drugmakers tend to produce more effective outcomes than independently funded studies, some have refuted the effect of industry bias on statin research.

Theodoratou says that differences in how studies were designed and potential bias may explain why some findings, like Alzheimer's, were significant in observational studies but not randomized trials. She also noted that how researchers rated the evidence is mostly based on "artbitrary thresholds, and currently no gold standard exists ... to truly quantify the risk of bias."

Ahern said, "they're very transparent about that," adding that the value in this analysis is figuring out where scientists should look next to better understand the impacts of statins.

"Which of these off-target, beneficial effects should we pour our research dollars and effort into pursuing?" he asked.

Similarly, Pencina called the new study "hypothesis-generating" and said it could be useful in better weighing the pros and cons of statins for people who are taking them for heart health.

Health experts say that no pill, including statins, should replace a healthy diet, exercise and avoiding smoking -- whose benefits extend well beyond heart health, research shows.

Huntsville
Overcast
41° wxIcon
Hi: 40° Lo: 23°
Feels Like: 34°
Florence
Overcast
41° wxIcon
Hi: 38° Lo: 25°
Feels Like: 34°
Fayetteville
Overcast
37° wxIcon
Hi: 40° Lo: 24°
Feels Like: 32°
Decatur
Overcast
41° wxIcon
Hi: 41° Lo: 23°
Feels Like: 33°
Scottsboro
Overcast
41° wxIcon
Hi: 41° Lo: 26°
Feels Like: 36°
WAAY Radar
WAAY WAAY-TV Cam
WAAY Temperatures

Alabama Coronavirus Cases

Cases: 247229

Reported Deaths: 3577
CountyCasesDeaths
Jefferson32718500
Mobile19904362
Madison13425148
Tuscaloosa13167154
Montgomery12380236
Shelby1046577
Baldwin882098
Lee778566
Morgan675150
Calhoun6366121
Etowah635166
Marshall630955
Houston532338
DeKalb489736
Cullman447442
Limestone430245
St. Clair425755
Lauderdale413354
Elmore409464
Walker3689111
Talladega353554
Jackson327123
Colbert314642
Blount294640
Autauga275142
Franklin254233
Coffee246515
Dale234454
Dallas226532
Chilton225038
Russell22313
Covington220334
Escambia198631
Chambers177250
Tallapoosa177091
Pike159214
Clarke158919
Marion141336
Winston134423
Lawrence129636
Pickens124218
Geneva12378
Marengo122524
Bibb118817
Barbour117511
Butler117342
Randolph103821
Cherokee102924
Hale97731
Fayette92216
Clay92024
Washington91619
Henry8676
Lowndes79929
Monroe79011
Cleburne77414
Macon74522
Crenshaw71230
Bullock70019
Perry6896
Conecuh68514
Lamar6838
Wilcox63918
Sumter58422
Greene42718
Choctaw42613
Coosa3464
Out of AL00
Unassigned00

Tennessee Coronavirus Cases

Cases: 366518

Reported Deaths: 4554
CountyCasesDeaths
Shelby47963660
Davidson42880420
Knox18930149
Rutherford17930161
Hamilton16861152
Williamson1149080
Sumner9817137
Out of TN776154
Wilson752678
Montgomery668083
Sullivan648597
Washington6073106
Putnam597582
Maury591867
Blount553161
Madison5368110
Bradley525234
Sevier493731
Unassigned484222
Robertson381253
Tipton371139
Hamblen350161
Gibson324265
Dyer322051
Greene311672
Anderson298729
Dickson293834
Coffee284841
Bedford278830
Carter274955
Lawrence270134
Obion268651
Cumberland261136
McMinn255055
Warren241020
Roane237029
Jefferson229533
Loudon229319
Fayette226938
Hardeman225337
Monroe217844
Weakley217837
Franklin211934
Lauderdale205823
Hawkins196834
Wayne192810
Trousdale190812
Henderson185434
Macon184628
Hardin179025
White176718
Marshall176520
Carroll176434
Rhea171431
Haywood163330
Cocke162330
Lincoln161416
Cheatham159817
Campbell155223
Overton155035
Henry154319
Giles147549
Smith145319
Johnson142421
McNairy141133
Fentress122120
Hickman119319
Lake11786
Bledsoe11745
DeKalb117322
Crockett115626
Marion110119
Scott10857
Chester102821
Grainger101518
Decatur95712
Unicoi86226
Claiborne8499
Benton81614
Grundy77914
Cannon7693
Lewis76514
Morgan7396
Union7225
Humphreys7198
Jackson68410
Polk67315
Stewart60115
Houston58820
Clay55418
Sequatchie5325
Meigs49513
Perry48421
Moore3943
Pickett38913
Van Buren3692
Hancock1723

Community Events